Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CARCINOMA, RENAL CELL - PATHOLOGY , . Treffer: 31

2017

Borgmann, H; Musquera, M; Haferkamp, A; Vilaseca, A; Klatte, T; Shariat, SF; Scavuzzo, A; Jimenez Rios, MA; Wolff, I; Capitanio, U; Dell'Oglio, P; Krabbe, LM; Herrmann, E; Ecke, T; Vergho, D; Huck, N; Wagener, N; Pahernik, S; Zastrow, S; Wirth, M; Surcel, C; Mirvald, C; Prochazkova, K; Hutterer, G; Zigeuner, R; Cindolo, L; Hora, M; Stief, CG; May, M; Brookman-May, SD Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
World J Urol. 2017; 35(12):1891-1897
Web of Science PubMed FullText FullText_MUG

 

May, M; Surcel, C; Capitanio, U; Dell'Oglio, P; Klatte, T; Shariat, S; Ecke, T; Wolff, I; Vergho, D; Wagener, N; Huck, N; Pahernik, S; Zastrow, S; Wirth, M; Borgmann, H; Haferkamp, A; Musquera, M; Krabbe, LM; Herrmann, E; Scavuzzo, A; Mirvald, C; Hutterer, G; Zigeuner, R; Stief, CG; Waidelich, R; Cindolo, L; Kalusova, K; Brookman-May, SD; Collaborative Research On Renal Neoplasms Association (CORONA) and European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
Scand J Urol. 2017; 51(4):269-276
Web of Science PubMed FullText FullText_MUG

 

Schanza, LM; Seles, M; Stotz, M; Fosselteder, J; Hutterer, GC; Pichler, M; Stiegelbauer, V MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(11): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wagener, N; Edelmann, D; Benner, A; Zigeuner, R; Borgmann, H; Wolff, I; Krabbe, LM; Musquera, M; Dell'Oglio, P; Capitanio, U; Klatte, T; Cindolo, L; May, M; Brookman-May, SD; European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
PLOS ONE. 2017; 12(9): e0184173-e0184173. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Mager, R; Daneshmand, S; Evans, CP; Palou, J; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Libertino, JA; Haferkamp, A; International Renal Cell Carcinoma-Venous Thrombus Consortium; Haferkamp, A; Capitanio, U; Carballido, JA; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; González, J; Hohenfellner, M; Huang, WC; Koppie, TM; Libertino, JA; Espinós, EL; Lorentz, A; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; O'Malley, P; Pahernik, S; Palou, J; Moreno, JL; Pruthi, RS; Faba, OR; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vázquez-Martul, D; Donoso, CV; Vergho, D; Wallen, EM; Zigeuner, R Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
J Surg Oncol. 2016; 114(6):764-768 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Brookman-May, SD; May, M; Wolff, I; Zigeuner, R; Hutterer, GC; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Feciche, B; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, Mdel C; Salzano, L; Lotrecchiano, G; Zastrow, S; Wirth, M; Sountoulides, P; Shariat, S; Waidelich, R; Stief, C; Gunia, S; CORONA Project; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
Eur Urol. 2015; 67(5):943-951 [Poster]
Web of Science PubMed FullText FullText_MUG

 

Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551
Web of Science PubMed FullText FullText_MUG

 

Hutterer, GC; Krieger, D; Mrsic, E; Pohlmann, K; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Anticancer Res. 2015; 35(6):3463-3469
Web of Science PubMed

 

Nguyen, HG; Tilki, D; Dall'Era, MA; Durbin-Johnson, B; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Espinós, EL; Mandel, P; Martinez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Rodriguez-Faba, O; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.
J Urol. 2015; 194(2):304-308 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Hutterer, GC; Stoeckigt, C; Stojakovic, T; Jesche, J; Eberhard, K; Pummer, K; Zigeuner, R; Pichler, M Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Urol Oncol. 2014; 32(7):1041-1048
Web of Science PubMed FullText FullText_MUG

 

Martínez-Salamanca, JI; Linares, E; González, J; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Nguyen, HG; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Faba, OR; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Curr Urol Rep. 2014; 15(5):404-404
Web of Science PubMed FullText FullText_MUG

 

May, M; Cindolo, L; Zigeuner, R; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Wolff, I; Feciche, B; Fenske, F; Pichler, M; Schips, L; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, Mdel C; Salzano, L; Lotrecchiano, G; Waidelich, R; Stief, C; Sountoulides, P; Brookman-May, S; Members of CORONA project; Young Academic Urologists Renal Cancer Group Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.
Urol Oncol. 2014; 32(8):1252-1258
Web of Science PubMed FullText FullText_MUG

 

Tilki, D; Nguyen, HG; Dall'Era, MA; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Eur Urol. 2014; 66(3):577-583
Web of Science PubMed FullText FullText_MUG

 

2013

Brookman-May, S; Langenhuijsen, JF; Volpe, A; Minervini, A; Joniau, S; Salagierski, M; Roscigno, M; Akdogan, B; Vandromme, A; Rodriguez-Faba, O; Marszalek, M Management of localized and locally advanced renal tumors. A contemporary review of current treatment options.
Minerva Med. 2013; 104(3):237-259
Web of Science PubMed

 

Senanayake, U; Koller, K; Pichler, M; Leuschner, I; Strohmaier, H; Hadler, U; Das, S; Hoefler, G; Guertl, B The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.
Hum Pathol. 2013; 44(3):336-345
Web of Science PubMed FullText FullText_MUG

 

2012

Brčić, I; Spajić, B; Krušlin, B Chromophobe renal cell carcinoma with rhabdoid differentiation in an adult.
Wien Klin Wochenschr. 2012; 124(11-12): 419-421. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma.
J Urol. 2012; 187(3):834-839
Web of Science PubMed FullText FullText_MUG

 

Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Eberhard, K; Hoefler, G; Pummer, K; Zigeuner, R Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
J Clin Pathol. 2012; 65(8):721-724
Web of Science PubMed FullText FullText_MUG

 

2011

Brčić, I; Leniček, T; Ulamec, M; Tomić, M; Krušlin, B Intrarenal ectopic adrenal tissue associated with renal angiomyolipoma.
Pathol Int. 2011; 61(12): 778-780.
Web of Science PubMed FullText FullText_MUG

 

2010

Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Eur Urol. 2010; 57(1): 102-109.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Gattenlohner, S; Etschmann, B; Riedmiller, H; Muller-Hermelink, HK Lack of KRAS and BRAF mutation in renal cell carcinoma.
Eur Urol. 2009; 55(6):1490-1491
Web of Science PubMed FullText FullText_MUG

 

Zigeuner, R; Pummer, K Predicting cancer-control outcomes in patients after nephron sparing surgery.
Arch Ital Urol Androl. 2009; 81(2): 91-95.
PubMed

 

2008

Hutterer, GC; Patard, JJ; Jeldres, C; Perrotte, P; de La Taille, A; Salomon, L; Verhoest, G; Tostain, J; Cindolo, L; Ficarra, V; Artibani, W; Schips, L; Zigeuner, R; Mulders, PF; Karakiewicz, PI Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram.
BJU Int. 2008; 101(1): 39-43. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Ficarra, V; Galfano, A; Guillé, F; Schips, L; Tostain, J; Mejean, A; Lang, H; Mulders, P; De La Taille, A; Chautard, D; Descotes, JL; Cindolo, L; Novara, G; Rioux-Leclercq, N; Zattoni, F; Artibani, W; Patard, JJ A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.
J Urol. 2007; 178(2):418-424
Web of Science PubMed FullText FullText_MUG

 

Karakiewicz, PI; Trinh, QD; Bhojani, N; Bensalah, K; Salomon, L; de la Taille, A; Tostain, J; Cindolo, L; Altieri, V; Ficarra, V; Schips, L; Zigeuner, R; Mulders, PF; Valeri, A; Descotes, JL; Mejean, A; Patard, JJ Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
EUR UROL. 2007; 51(6): 1616-1624.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schips, L; Dalpiaz, O; Lipsky, K; Langner, C; Rehak, P; Puerstner, P; Pummer, K; Zigeuner, R Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Eur Urol. 2007; 51(1): 168-173.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Ficarra, V; Guillè, F; Schips, L; de la Taille, A; Prayer Galetti, T; Tostain, J; Cindolo, L; Novara, G; Zigeuner, R; Bratti, E; Li, G; Altieri, V; Abbou, CC; Zanolla, L; Artibani, W; Patard, JJ Proposal for revision of the TNM classification system for renal cell carcinoma.
Cancer. 2005; 104(10):2116-2123 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Wolf, G; Aigner, RM; Humer-Fuchs, U; Schwarz, T; Krippl, P; Wehrschuetz, M Renal cell carcinoma metastasis in a microfollicular adenoma of the thyroid gland.
Acta Med Austriaca. 2002; 29(4):141-142 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1990

Vilits, P; Colombo, T; Hubmer, G Renal cell carcinoma with venous invasion: therapy--prognosis
Helv Chir Acta. 1990; 57(3): 459-461.
Web of Science PubMed Google Scholar

 

1987

Schmid, C; Beham, A Angiosarcoma of the liver and renal cell carcinoma with panmyelopathy following Thorotrast administration 40 and 41 years ago. Case reports with immunohistochemical studies
Pathologe. 1987; 8(3):177-182 (- Case Report)
Web of Science PubMed

 

© Med Uni Graz Impressum